Literature DB >> 20559644

[Diseases of the outer eye in rheumatoid arthritis].

E Feist1, U Pleyer.   

Abstract

Eye involvement is a frequent finding in patients with rheumatoid arthritis and may represent the leading clinical manifestation of disease. In this context, all components of the visual organ might be affected. The main spectrum of eye involvement comprises keratoconjunctivitis sicca, episcleritis and scleritis as well as ulcerative keratitis. As with the underlying disease, autoimmune reactions based on a patient's genetic predisposition are assumed to be of significance in disease pathogenesis. Emerging evidence also points to additional morphological and physiological ocular characteristics in the pathogenesis of the various ocular pathologies. This article gives an overview of clinical aspects, pathogenetic background as well as therapeutic options for ocular involvement in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559644     DOI: 10.1007/s00393-009-0577-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  50 in total

1.  Incidence of ocular complications in rheumatoid arthritis and the relation of keratoconjunctivitis sicca with its systemic activity.

Authors:  T Matsuo; R Kono; N Matsuo; K Ezawa; M Natsumeda; K Soda; H Ezawa
Journal:  Scand J Rheumatol       Date:  1997       Impact factor: 3.641

2.  Increased resistance of crosslinked cornea against enzymatic digestion.

Authors:  Eberhard Spoerl; Gregor Wollensak; Theo Seiler
Journal:  Curr Eye Res       Date:  2004-07       Impact factor: 2.424

Review 3.  Scleritis.

Authors:  Narciss Okhravi; Bola Odufuwa; Peter McCluskey; Susan Lightman
Journal:  Surv Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 6.048

4.  Suppression of immune-mediated ocular inflammation in mice by interleukin 1 receptor antagonist administration.

Authors:  Wee-Kiak Lim; Chiaki Fujimoto; Roxana Ursea; Sankaranarayana Pillai Mahesh; Phyllis Silver; Chi-Chao Chan; Igal Gery; Robert B Nussenblatt
Journal:  Arch Ophthalmol       Date:  2005-07

Review 5.  Ophthalmologic manifestations of rheumatic diseases.

Authors:  F Hamideh; P E Prete
Journal:  Semin Arthritis Rheum       Date:  2001-02       Impact factor: 5.532

6.  Successful treatment of severe nodular scleritis with adalimumab.

Authors:  Juan P Restrepo; María P Molina
Journal:  Clin Rheumatol       Date:  2010-02-14       Impact factor: 2.980

7.  Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis.

Authors:  G P Riley; R L Harrall; P G Watson; T E Cawston; B L Hazleman
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

8.  Peripheral ulcerative keratitis in the setting of rheumatoid arthritis: treatment with immunosuppressive therapy.

Authors:  H Jifi-Bahlool; C Saadeh; J O'Connor
Journal:  Semin Arthritis Rheum       Date:  1995-08       Impact factor: 5.532

9.  Cells perpetuating the inflammatory response in scleritis.

Authors:  W Bernauer; P G Watson; B Daicker; S Lightman
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

10.  Immunopathology of necrotising scleritis.

Authors:  Yoshihiko Usui; Jignesh Parikh; Hiroshi Goto; Narsing A Rao
Journal:  Br J Ophthalmol       Date:  2008-03       Impact factor: 4.638

View more
  2 in total

Review 1.  [Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].

Authors:  I Kötter; N Stübiger; C Deuter
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

2.  Corneal perforation as a primary manifestation of keratoconus in a patient with underlying rheumatoid arthritis.

Authors:  Konstantinos T Tsaousis; Nikolaos Chalvatzis; Chrysanthos Symeonidis; Nikolaos Kopsachilis; Asimina Mataftsi; Stavros A Dimitrakos; Ioannis T Tsinopoulos
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.